
08/07/2025
Exciting milestone! 🇸🇮
Argent BioPharma has officially started using our EU-GMP API to treat drug-resistant epilepsy at Slovenia’s largest hospital. Proud that PHCANN International’s products are now reaching patients in Slovenia through this impactful partnership.
Another step forward for medical cannabis in Europe.
Argent BioPharma (ASX:RGT) initiates supply of EU-GMP Cannabinoid API for epilepsy treatment at Slovenia’s largest hospital.